Entecavir

Type: Keyphrase

Name: Entecavir

First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents (in Health)

Entecavir (Baraclude) and Tenofovir (Viread) Rescue Therapy for Chronic Hepatitis B Patients with Advanced Fibrosis and Prior Treatment Failure

In this open-label cohort study, investigators from 8 referral centers in Europe assessed the efficacy and safety of tenofovir plus entecavir in treatment-experienced hepatitis B patients with advanced liver disease. Past treatment with single nucleoside/nucleotide ... [HIV and Hepatitis.com - 11/18/2009]

Entities: Tenofovir, Entecavir, fibrosis, Hepatitis B, Hamburg

First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents

Patients Previously Treated With Adefovir Can Achieve Complete Viral Suppression When Switched to Entecavir: Presented at AASLD

-- Patients with hepatitis B virus (HBV) previously treated with adefovir (ADV) had complete viral suppression (CVS) and alanine aminotransferase (ALT) normalisation when switched to entecavir (ETV), researchers stated here at the Liver Meeting 2009, ... [PSL Group - 11/03/2009]

Entities: Entecavir, Adefovir, Suppression

First Reported 11/04/2009 - Updated 11/04/2009 - 1 Documents (in Health)

Entecavir Achieves High Response Rate In Real-life Clinical Management Of Patients With Chronic Hepatitis B

The nucleoside analogue entecavir (Baraclude, Bristol-Myers Squibb) achieves a high response rate and progressive decline in liver stiffness in patients with chronic hepatitis B, according to results from the first study in 'real-life' clinical practice ... [Medical News Today - 11/04/2009]

Entities: Entecavir, Hepatitis B, Virus, hepatic, Cirrhosis

First Reported 11/06/2009 - Updated 11/06/2009 - 1 Documents (in Medicine)

Entecavir (Baraclude) Demonstrates Greater Antiviral Activity than Adefovir (Hepsera) in Hepatitis B Patients with Decompensated Liver Disease

To explore this issue, an international team of investigators conducted a randomized, open-label, Phase 3b study (ETV-048) comparing 1.0 mg/day entecavir versus 10 mg/day adefovir in this population. A total of 100 participants randomly assigned to the ... [HIV and Hepatitis.com - 11/06/2009]

Entities: Adefovir, Entecavir, Hepatitis B, Antiviral

First Reported 11/09/2009 - Updated 11/09/2009 - 1 Documents (in Chemistry)

Entecavir for the long-term treatment of chronic hepatitis B

Expert Review of Anti-infective Therapy ... [MDLinx - 11/09/2009]

Entities: Entecavir

First Reported 11/11/2009 - Updated 11/11/2009 - 1 Documents

Loss of HBsAg in Nucleoside-Naïve HBeAg(+) Chronic Hepatitis B Patients Following Treatment with Entecavir or Lamivudine: Evaluation of HBV Genotypes

AASLD 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA, Hynes Convention Center October 30-November 3, 2009 Reported by Jules Levin AASLD, The Liver Meeting in Boston, MA, October 30 - November 3, 2009 Robert ... [National AIDS Treatment Advocacy Project - 11/11/2009]

Entities: Genotype, lamivudine, Entecavir, Hepatitis B

First Reported 06/23/2009 - Updated 06/23/2009 - 1 Documents

EDITORIAL: Entecavir Surprise

The truly remarkable advances in the treatment of human immunodeficiency virus type 1 (HIV-1) infection have turned a once nearly uniform death sentence into a treatable condition. The survival benefits... ... [NEJM â Collection Updates for Viral Diseases - 06/23/2009]

Entities: Entecavir, HIV/AIDS

First Reported 06/23/2009 - Updated 06/23/2009 - 1 Documents

ORIGINAL ARTICLE: The HBV Drug Entecavir â Effects on HIV-1 Replication and Resistance

Entecavir, a drug approved by the Food and Drug Administration for the treatment of chronic hepatitis B virus (HBV) infection, is not believed to inhibit replication of human immunodeficiency virus... ... [NEJM â Collection Updates for Viral Diseases - 06/23/2009]

Entities: Entecavir, Hepatitis B Virus, Replication

First Reported 10/13/2009 - Updated 10/13/2009 - 1 Documents

Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus Infection

Alabama, Florida, Illinois, Louisiana, Maryland, Massachusetts, Michigan, New York, Pennsylvania, Rhode Island, Texas; Brazil, Mexico, South Africa. clinicaltrials.gov|This story published in Digestive Health SmartBrief on 10/14/2009More from SmartBr ... [SmartBrief - 10/13/2009]

Entities: Entecavir, Hepatitis B Virus, Hispanics, African-Americans

First Reported 10/15/2009 - Updated 10/15/2009 - 1 Documents

Hepatitis B-Associated Acute Liver Failure: Immediate Treatment with Entecavir Inhibits Hepatitis B Virus Replication and Potentially Its Sequelae

1. Report Shows Shift in Starting Salaries for Physicians2. Use of Antiemetic Agents in Acute Gastroenteritis3. 2008 Exclusive SurveyEarnings: Good news for primary care income4. Medicare pay-for-reporting effort draws fire from frustrated doctors5. Debunking ... [MDLinx - 10/15/2009]

Entities: Entecavir, Hepatitis B Virus, Replication

Quotes

...' However, they added, "More data are certainly needed to judge about the long-term safety, efficacy and prevention of emergence of new viral mutations in this difficult to treat patient population." Asklepiosklinik St...

Entecavir (Baraclude) and Tenofovir (Viread) Rescue Therapy for Chronic Hepatitis B Patients with ... [HIV and Hepatitis.com - 11/18/2009]

...[kidney] events was low and no significant renal safety difference was observed between groups in this vulnerable population,' they continued. "HBeAg loss or seroconversion was only observed in the [tenofovir] containing regimens." Chang-Gung Memorial Hospital - LinKou, Taoyuan Hsien, Taiwan; Gilead Sciences, Durham, NC; Chang-Gung Memorial Hospital - Kaohsiung, Kaoshiung Hsien...

Tenofovir (Viread) Regimens Are Effective and Well-tolerated in Chronic Hepatitis B Patients with ... [HIV and Hepatitis.com - 11/06/2009]

...patient population,' said ETV-048 study investigator Hugo Cheinquer in a press release issued by entecavir manufacturer Bristol-Myers Squibb. "Chronic hepatitis B is a lifelong disease and these data suggest that treatment with Baraclude may offer patients with decompensated cirrhosis a treatment option." Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan; Aristotle University of Thessaloniki, Thessaloniki, Greece;...

Entecavir (Baraclude) Demonstrates Greater Antiviral Activity than Adefovir (Hepsera) in Hepatiti ... [HIV and Hepatitis.com - 11/06/2009]

Log in to Silobreaker

Advanced Search Options

Entecavir